HIV/AIDS
Researchers from Japan, Iran and the United States publish new studies and findings in the area of HIV/AIDS
Published in Vaccine Weekly, September 13th, 2006
Study 1: Sequential immunization with HIV-1 V3 peptides produces cross-neutralizing antibodies.
"An antibody response capable of neutralizing not only homologous but also heterologous forms of the CXCR4-tropic human immunodeficiency virus type I (HIV-1) MNp and CCR5-tropic primary isolate HIV-1 JR-CSF was achieved through sequential immunization with a combination of synthetic peptides representing HIV-1 Env V3 sequences from field and laboratory HIV-1 clade B isolates.
"In contrast, repeated immunization with a single V3 peptide generated...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2006-09-13)
More Articles from Vaccine Weekly
- Dengue Vaccine
Live attenuated tetravalent dengue vaccine was safe, effective in Thai children - Malaria Vaccine
Malaria vaccine RTS,S/AS02A is safe and immunogenic in Kenyan adults - Pneumococcal Vaccine
Cost-effectiveness of 7-valent pneumococcal conjugate vaccine was evaluated - Schistosomiasis Vaccine
Schistosoma mansoni tetraspanins protect against schistosomiasis - Vector Development
Dendritic cationic lipids with charged headgroups provide efficient gene delivery - Adrenocortical Cancer
Adrenocortical carcinoma immunotherapy elicits angiogenic stability but not clinical improvement - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
